Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Swanson

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical and Vaccine Immunology : CVI|July 20, 2007
Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodiesJohn Ferbas, John Thomas, John Hodgson, et al.
Journal of Immunological Methods|August 13, 2013
Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interferenceDohan K Weeraratne, James Lofgren, Steve Dinnogen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 24, 2011
Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparisonTroy E Barger, Andrew J Kuck, Narendra Chirmule, et al.
The AAPS Journal|December 17, 2009
Comparing exponentially weighted moving average and run rules in process control of semiquantitative immunogenicity immunoassaysTroy E Barger, Lei Zhou, Michael Hale, et al.
Bioanalysis|November 19, 2010
Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessmentAmi C Bautista, Danika Wullner, Mike Moxness, et al.
Journal of Immunological Methods|September 23, 2006
A novel method for detecting neutralizing antibodies against therapeutic proteins by measuring gene expressionYanbin Yu, Christopher Piddington, Dan Fitzpatrick, et al.
The AAPS Journal|July 24, 2009
A step-wise approach for transfer of immunogenicity assays during clinical drug developmentSuzanna Tatarewicz, Michael Moxness, Dohan Weeraratne, et al.
Journal of Clinical Immunology|July 17, 2007
Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusionSuzanna M Tatarewicz, Xin Wei, Shalini Gupta, et al.
Journal of Immunological Methods|March 2, 2010
Identification and inhibition of drug target interference in immunogenicity assaysZhandong D Zhong, Steve Dinnogen, Martha Hokom, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 19, 2011
Strategy to confirm the presence of anti-erythropoietin neutralizing antibodies in human serumSergio Sanchez, Troy Barger, Lei Zhou, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical and Vaccine Immunology : CVI|July 20, 2007
Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodiesJohn Ferbas, John Thomas, John Hodgson, et al.
Journal of Immunological Methods|August 13, 2013
Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interferenceDohan K Weeraratne, James Lofgren, Steve Dinnogen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 24, 2011
Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparisonTroy E Barger, Andrew J Kuck, Narendra Chirmule, et al.
The AAPS Journal|December 17, 2009
Comparing exponentially weighted moving average and run rules in process control of semiquantitative immunogenicity immunoassaysTroy E Barger, Lei Zhou, Michael Hale, et al.
Bioanalysis|November 19, 2010
Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessmentAmi C Bautista, Danika Wullner, Mike Moxness, et al.
Journal of Immunological Methods|September 23, 2006
A novel method for detecting neutralizing antibodies against therapeutic proteins by measuring gene expressionYanbin Yu, Christopher Piddington, Dan Fitzpatrick, et al.
The AAPS Journal|July 24, 2009
A step-wise approach for transfer of immunogenicity assays during clinical drug developmentSuzanna Tatarewicz, Michael Moxness, Dohan Weeraratne, et al.
Journal of Clinical Immunology|July 17, 2007
Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusionSuzanna M Tatarewicz, Xin Wei, Shalini Gupta, et al.
Journal of Immunological Methods|March 2, 2010
Identification and inhibition of drug target interference in immunogenicity assaysZhandong D Zhong, Steve Dinnogen, Martha Hokom, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 19, 2011
Strategy to confirm the presence of anti-erythropoietin neutralizing antibodies in human serumSergio Sanchez, Troy Barger, Lei Zhou, et al.
Pageof 5